IP Library Granted Patent US 10,494,667
Granted Patent B2
US 10,494,667 · App. 16/437,637 · Granted Dec 3, 2019

Spatially encoded biological assays

Inventor: Mark S. Chee (San Diego, CA)
Assignee: Prognosys Biosciences, Inc.
C12Q1/6837C12Q1/6804C12Q1/6809C12Q1/6834C12Q1/6841C12Q1/6869C12Q1/6874C40B30/04C40B60/04G01N33/5308G01N33/6845G01N2458/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,494,667
App. No.
16/437,637
Filed
Jun 11, 2019
Granted
Dec 3, 2019
Kind
B2
Art Unit
1634
USPC
435/6.1
Abstract

The present invention provides assays and assay systems for use in spatially encoded biological assays. The invention provides an assay system comprising an assay capable of high levels of multiplexing where reagents are provided to a biological sample in defined spatial patterns; instrumentation capable of controlled delivery of reagents according to the spatial patterns; and a decoding scheme providing a readout that is digital in nature.

Claims (45)

1. A method of determining the presence or abundance of a plurality of biological molecules in a location of interest in a biological sample comprising:

(a) contacting the biological sample with a first and a second probe for each of the plurality of biological molecules, wherein a first and second probe for each biological molecule each comprise a sequence that is complementary to a sequence in the biological molecule, and when the first and second probes are hybridized to the biological molecule, the first and second probes are capable of being ligated together;

(b) imaging the biological sample to identify the location of interest;

(c) ligating first and second probes that are hybridized to a biological molecule to generate a ligation product(s) having a sequence;

(d) separating the ligation product(s) from the location of interest in the biological sample; and

(e) determining the sequence of the separated ligation product(s), thereby determining the presence or abundance of the plurality of biological molecules at the location of interest in the biological sample,

wherein step (b) is performed before step (d).

2. The method of claim 1 , further comprising, after step (a), washing unhybridized first and second probes from the biological sample.

3. The method of claim 1 , wherein step (b) is performed before step (a), between step (a) and step (c), or between step (c) and step (d).

4. The method of claim 1 , wherein the plurality of biological molecules is RNA or DNA.

5. The method of claim 1 , wherein the plurality of biological molecules represents a transcriptional pattern in the location of interest of the biological sample.

6. The method of claim 1 , wherein the support is a slide or a culture dish.

7. The method of claim 1 , wherein the biological sample is affixed to a support.

8. The method of claim 1 , wherein the biological sample affixed to the support is a paraformalin-fixed, paraffin-embedded (FFPE) or frozen sample.

9. The method of claim 1 , wherein the imaging is performed using microscopy.

10. The method of claim 1 , determining the sequence of the separated ligation product(s) includes the performance of high-throughput, next-generation sequencing.

11. The method of claim 1 , further comprising a step of amplifying the ligation product(s) between the separating step and the determining step.

12. A method of determining the presence or abundance of a plurality of biological molecules in a location of interest in a biological sample comprising:

(a) imaging a biological sample to identify the location of interest;

(b) contacting the location of interest in the biological sample with a first and a second probe for each of the plurality of biological molecules, wherein a first and second probe for each biological molecule each comprise a sequence that is complementary to a sequence in the biological molecule, and when the first and second probes are hybridized to the biological molecule, the first and second probes are capable of being ligated together;

(c) ligating first and second probes that are hybridized to a biological molecule in the location of interest in the biological sample to generate a ligation product(s) having a sequence;

(d) separating the ligation product(s) from the location of interest in the biological sample; and

(e) determining the sequence of the separated ligation product(s), thereby determining the presence or abundance of the plurality of biological molecules in the location of interest in the biological sample.

13. The method of claim 12 , further comprising, after step (b), washing unhybridized first and second probes from the biological sample.

14. The method claim 12 , wherein the plurality of biological molecules is RNA or DNA.

15. The method of claim 14 , wherein the plurality of biological molecules represents a transcriptional pattern in the location of interest of the biological sample.

16. The method of claim 12 , wherein the support is a slide or a culture dish.

17. The method of claim 12 , wherein the biological sample is affixed to a support.

18. The method of claim 12 , wherein the biological sample affixed to the support is a paraformalin-fixed, paraffin-embedded (FFPE) or frozen sample.

19. The method of claim 12 , wherein the imaging is performed using microscopy.

20. The method of claim 12 , determining the sequence of the separated ligation product(s) includes the performance of high-throughput, next-generation sequencing.

21. The method of claim 12 , further comprising a step of amplifying the ligation product(s) between the separating step and the determining step.

22. A method of determining the presence or abundance of a plurality of biological molecules in a location of interest in a biological sample comprising:

(a) imaging a biological sample to identify the location of interest;

(b) contacting the location of interest in the biological sample with a first and a second probe for each of the plurality of biological molecules, wherein a first and second probe for each biological molecule each comprise a sequence that is complementary to a sequence in the biological molecule, and when the first and second probes are hybridized to the biological molecule, the first and second probes are capable of being ligated together;

(c) ligating first and second probes that are hybridized to a biological molecule in the biological sample to generate a ligation product(s) having a sequence;

(d) separating the ligation product(s) from the biological sample;

(e) determining the sequence of the separated ligation product(s), thereby determining the presence or abundance of the plurality of biological molecules in the location of interest in the biological sample.

23. The method of claim 22 , further comprising, after step (b), washing unhybridized first and second probes from the biological sample.

24. The method claim 22 , wherein the plurality of biological molecules is RNA or DNA.

25. The method of claim 22 , wherein the plurality of biological molecules represents a transcriptional pattern in the location of interest of the biological sample.

26. The method of claim 22 , wherein the support is a slide or a culture dish.

27. The method of claim 22 , wherein the biological sample is a frozen sample or a paraformalin-fixed, paraffin-embedded (FFPE) sample.

28. The method of claim 22 , determining the sequence of the separated ligation product(s) includes the performance of high-throughput, next-generation sequencing.

29. The method of claim 22 , further comprising a step of amplifying the ligation product(s) between the separating step and the determining step.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2019
From: CHEE, MARK S.
To: PROGNOSYS BIOSCIENCES, INC.
Reel/Frame 049440/0744 →
Continuity (8)
Continuation 16430015 · Jun 3, 2019
Continuation 16414213 · May 16, 2019
Continuation 16402098 · May 2, 2019
Continuation 16276235 · Feb 14, 2019
Continuation 15187661 · Jun 20, 2016
Continuation 13080616 · Apr 5, 2011
Provisional Application 61321124 · Apr 5, 2010
Related Publication 20190309354A1 · Oct 10, 2019
Cited By (46)
US 12,195,790 US 12,203,134 US 12,203,136 US 12,209,280 US 12,223,751 US 12,228,544 US 12,241,060 US 12,241,890 US 12,249,085 US 12,264,358 US 12,265,079 US 12,270,077 US 12,275,988 US 12,281,357 US 12,286,673 US 12,287,264 US 12,297,486 US 12,331,347 US 12,344,892 US 12,365,935 US 12,365,942 US 12,371,688 US 12,378,607 US 12,385,083 US 12,399,123 US 12,405,264 US 12,416,603 US 12,435,363 US 12,442,045 US 12,467,086 US 12,497,654 US 12,508,590 US 12,545,949 US 12,553,805 US 12,553,898 US 12,559,790 US 12,565,671 US 12,566,113 US 12,566,114 US 12,571,029 US 12,618,099 US 12,624,475 US 12,637,706 US 12,692,492 US 12,723,275 US 12,735,743